AI Labs Push DNA Screening - TCR 06/04/26
OpenAI, Anthropic, DeepMind, Microsoft, and Meta backed DNA order screening while an open model powered a self-spreading worm.
The 20-Second Scan
- The Allen Institute launched a $400M Brain Health accelerator to develop genetic therapies for Alzheimer's, Parkinson's, ALS, Huntington's, and related disorders.
- Google will fund a three-year 100-MW virtual power plant in PJM as Massachusetts prepares parked EVs to feed the grid.
- OpenAI, Anthropic, Google DeepMind, and Microsoft AI leaders co-signed a synthetic-DNA screening letter as a free open model powered a self-spreading worm.
- Martin Scorsese disclosed a Black Forest Labs partnership and said he uses generative AI storyboards, drawing backlash from storyboard and concept artists.
- Alnylam and Inceptive formed a $2B RNAi discovery collaboration as Mayo and Microsoft moved to build a Mayo-owned healthcare AI model.
- Microsoft, Meta, and Morgan Stanley moved agent-first interfaces into devices, business messaging, and stock-plan administration infrastructure.
Track all of the arcs The Century Report covers here:
The 2-Minute Read
The day’s signal is a set of old ceilings becoming workable surfaces. Brain disease moves from mapping toward intervention. Grid demand meets a response assembled from assets already sitting in homes, buildings, factories, and parked vehicles. Medical discovery shifts toward models and spatial assays trained on the data that used to stay locked inside institutions.
The AI layer carries the most tension. Rival labs converged on a biosecurity ask that hardens one physical chokepoint, while a free open model showed that dangerous cyber automation already diffuses below the frontier tier. That pairing is important because it keeps the governance focus honest: risk does not live only where large companies can meter access.
Creative work and everyday computing are crossing their own thresholds. Scorsese’s move into AI storyboarding does not erase artists’ consent and credit concerns; it makes the simple refusal frame harder to sustain. A filmmaker identified with cinema’s depth is testing generative imagery as a way to communicate intention.
The agent shift is the broadest interface change. Microsoft is sketching devices around agents, Meta is placing them inside business messaging, and Morgan Stanley is preparing regulated financial systems for machine-mediated access. The screen is giving way to permissioned action, and the next build is about trust, logs, revocation, and who gets to act for whom.
The 20-Minute Deep Dive
The Allen Institute Moves From Mapping the Brain to Editing Its Diseases
The Allen Institute launched a $400 million Brain Health accelerator built around a premise that would have sounded premature for most of modern neuroscience: scientists now know enough about the brain's cellular machinery to begin designing genetic therapies for the disorders that break it. The initiative targets Alzheimer's, Parkinson's, ALS, Lewy body dementia, Huntington's, and related conditions. Its funding includes $200 million from the Allen Institute, $100 million from the Bezos family, and $100 million from sources including the NIH, Amazon Web Services, and EverythingALS.
The shift is important because the Allen Institute helped build much of the map it now wants to treat. Its work on cell atlases, brain-cell taxonomies, and open databases helped move neuroscience from gross anatomy and symptom clusters toward a cell-type and gene-program view of disease - the kind of cellular precision the June 1 edition of The Century Report tracked when a gene-editing selection gate pushed somatic CRISPR editing of blood stem cells past its long-standing efficiency bottleneck, opening blood disorders to precise correction rather than disruption. Ed Lein, who directs the institute's brain health programs, framed the new therapeutic opening around genetic treatments that can control particular genes with much greater specificity than older interventions allowed. That is the move from observing degeneration to protecting the cell populations that disease attacks first.
Huntington's disease is one example of shows why this accelerator exists. Jeff Carroll, a scientist who carries the Huntington's gene and watched his mother develop the disease, described the logic plainly: if a single gene drives production of the toxic protein, then a therapy that reduces or controls that gene's activity could change the disease course. A small academic lab can study that hypothesis. A large accelerator can build the delivery systems, cell models, assays, and clinical translation pipeline needed to test it at therapeutic scale.
A Johns Hopkins study published alongside this brain-health moment added a second signal from the same frontier: habits may form far faster than scientists previously thought, with researchers identifying a brain region involved in the shift from deliberate action to automatic behavior. The brain is becoming less mysterious in two directions at once - as a system that degenerates through specific cellular pathways, and as a system that changes behavior through identifiable circuits. While that does not make treatment easy, it does make the intervention surface more visible.
Google Funds the Grid-Flexibility Workaround
Google will fund a three-year, 100-MW virtual power plant in the PJM Interconnection through Voltus, which will aggregate distributed energy resources from residential, commercial, and industrial customers across the grid operator’s territory. The company described the deal as a scalable blueprint for unlocking capacity to meet data center demand, and Voltus said the resources will come from customers already capable of shifting or dispatching electricity when the grid needs relief.
The important detail is the reasoning Google put on the record. Amanda Peterson Corio, Google's global head of data center energy, told Utility Dive that the company has worked to make its own data centers flexible, but that it is often faster and more cost effective to pay other customers to shift electricity usage. That is a very different posture from the hyperscaler pattern the May 29 edition of The Century Report tracked: buying reactor output, signing multi-gigawatt PPAs, building captive gas plants, or pushing utilities to expand supply around computational load. Here the load growth is still immense, but the response reaches first for latent flexibility already sitting in the system.
PJM is the right place for that experiment. Capacity prices have spiked, reserve margins have tightened, and data center interconnection has become a defining stressor in the region. Google and Voltus emphasized that expanding the grid to serve short peaks is one of the main drivers of customer costs, because much of the resulting infrastructure sits unused most of the year. A virtual power plant attacks that mismatch directly. Instead of building every megawatt as though peak demand were permanent demand, it pays existing devices, buildings, batteries, and industrial processes to behave as a coordinated resource.
Massachusetts is adding another piece of the same distributed layer as parked EVs begin feeding power back to the grid through a summer vehicle-to-grid program. Constellation’s Three Mile Island nuclear restart also moved forward with a FERC waiver, showing the firm-clean side of the same response. The compute buildout is pulling from both ends: flexible demand from below, firm generation from above. When demand grows faster than generation and transmission can be built, flexibility becomes capacity.
The Bioweapons Letter Meets the Open-Model Worm
Leaders from OpenAI, Anthropic, Google DeepMind, Microsoft AI, Meta, and other organizations co-signed an open letter urging lawmakers to require screening of synthetic nucleic acid orders. The letter, organized by the Institute for Progress and the Foundation for American Innovation, asks for sequence-of-concern checks, customer legitimacy checks, order records, and traceability for companies that synthesize DNA or related biological material. The signatories framed AI as raising the urgency because knowledge barriers around biological weapons may erode as models improve.
That narrow ask is significant because it targets the biological supply chain rather than the model layer alone. A model can lower the cost of knowledge, but a dangerous biological design still has to cross a physical chokepoint before it becomes material. Screening synthesis orders is one of the few governance moves that operates where digital capability meets atoms. The letter’s convergence across rival labs is useful data about shared exposure, and it also deserves the usual skepticism: the same companies asking lawmakers to harden downstream gates benefit when the public risk story centers the frontier systems they can meter, audit, and selectively release.
The second development makes that tension sharper. A researcher showed that a free open-source model could help build a self-spreading worm inside an enterprise test network without Mythos-class access or zero-day vulnerabilities. The Register's summary quotes the researchers' warning that attackers can cheaply operationalize known vulnerabilities at scale. That is the floor moving, rather than the ceiling. The frontier labs may be right that powerful systems can reduce biological and cyber barriers. The worm demonstration shows the risky capability no longer lives only inside the gated frontier, extending the pattern The Century Report documented on May 31 when abliterated open-weight models began running at frontier-tier capability on inexpensive hardware outside any platform's revocation reach.
There is hope, however, and it lives in the specificity of what we're seeing here. The field is getting better at identifying where the physical and procedural gates actually are: DNA synthesis screens, customer verification, vulnerability patch pipelines, credential custody, network segmentation, phone-scam detection, and defensive access programs. Broad fear tells people to freeze. Concrete gates tell builders where to reinforce, and they turn a generalized anxiety about capability into an engineering agenda.
The same evidence exposes the limit of treating frontier access as the center of safety: dangerous work now moves through ordinary supply chains, known vulnerabilities, and physical synthesis orders that can be checked directly. That makes the DNA-screening ask more than a lab-interest policy move; it is one of the first places where rival AI labs are conceding that shared exposure beats private control.
Scorsese Crosses the Creative Fault Line
Martin Scorsese’s disclosure that he is a partner and adviser to Black Forest Labs, and that he has tested generative AI for storyboards, sharpened a creative-industry split that has been building for months. Storyboard and concept artists reacted angrily, with Karla Ortiz accusing him of throwing artists “under the bus” and Samuel Deats saying there was no reason to rely on AI systems trained on artists’ work. Their objection is concrete: if generative systems absorb the visual labor of working artists without consent or compensation, the efficiency Scorsese described can arrive as lost work and lost credit for the people who normally translate a director’s imagination into production language.
Scorsese’s own framing points somewhere more interesting than simple automation. He told the New York Times that he has been making his own storyboards for decades and has long faced the problem of communicating what he sees in his head to cast and crew. He described the ability to visualize and share a scene during preproduction as creatively freeing, and emphasized that he is testing AI in preparation rather than putting generated images into a film. The distinction is meaningful here. This is a director using generative imagery as a bridge between private vision and collective production, rather than as a finished cinematic surface.
Scorsese is one of the living filmmakers most associated with defending cinema as serious art against flattening industrial formula. His move into generative AI does not settle the labor and consent fights around training data. It does puncture the lazy binary that treats AI as inherently opposed to meaningful cinema. A filmmaker whose public identity rests on the moral and aesthetic weight of the medium is saying the new capability can help him communicate intention more clearly.
This continues the Cannes fracture that The Century Report tracked on May 24, when Darren Aronofsky announced a DeepMind partnership while Guillermo del Toro rejected AI outright. Scorsese makes the split harder to categorize because he carries the authority of preservation into the act of experimentation. The dispute reads as a labor-and-consent fight only as long as the creative field stays organized around the roles AI is making fluid. That organization is real, and so is the loss inside it - Ortiz and Deats are watching skills they spent careers earning become things anyone can summon, and the fear that follows is borne of arithmetic, not nostalgia. But the argument moving beneath the surface goes far beyond whether that skill should stay scarce - it's about who owns it once it isn't. Strip craft of its scarcity and what's left is imagination itself, in principle open to anyone - unless the capacity to wield it is fenced, metered, and rented back by whoever holds the models. The real fight isn't man versus machine. It's commons versus enclosure: whether a power that could belong to everyone becomes one more thing a few own and the rest pay to reach.
Healthcare Models and Spatial Maps Compress the Medical Feedback Loop
Microsoft and Mayo Clinic announced a partnership to develop a frontier healthcare AI model owned by Mayo and trained on the health system’s de-identified clinical data and longitudinal expertise. The partners said the system is meant to support clinical reasoning, earlier diagnosis, and more personalized treatment decisions. Mayo will deploy it internally first, where it can be tested and refined through clinical use, before Microsoft makes it available through Azure Foundry APIs. The ownership detail is significant: the model is being built around a clinical institution’s data foundation rather than simply routing healthcare work through a general-purpose external system.
That pattern sits beside a second medical development from Nature Biotechnology: single-cell spatial pharmacobiology, or SSP, a method for seeing why antibody drugs fail inside solid tumors. Researchers infused patients with a fluorescently labeled EGFR-targeting antibody, then combined imaging with high-plex spatial proteomics to map where the drug went, which cells it reached, how well it engaged its target, and how the tumor microenvironment shaped that access. In head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma, SSP identified conserved barriers that reduced antibody delivery, including periostin-rich extracellular matrix regions and fibroblast-activation-protein-positive cancer-associated fibroblast neighborhoods.
Alnylam and Inceptive added the therapeutic-data side of the same pattern with a collaboration valued at up to $2 billion. Alnylam brings two decades of RNAi discovery and development data; Inceptive brings foundation models for RNA therapeutics. The point is less the headline value than the data posture. Proprietary therapeutic history is being treated as training substrate for discovery systems, because the cost of failed molecules is high enough to make better shared machinery attractive even inside a competitive field.
The diagnostic edge is moving too. Zepto Life Technology received FDA Breakthrough Device Designation for FungiFlex Mold Panel, a plasma liquid biopsy that detects fungal cell-free DNA and identifies invasive mold pathogens including Aspergillus, Mucorales, Fusarium, and Scedosporium/Lomentospora. Edwards Lifesciences won FDA approval for Triformis Resilia, the first surgical valve replacement designed specifically for tricuspid valve disease. The combined picture is medicine becoming less episodic and less blind: models read across records, spatial assays read inside tumors, liquid biopsies read pathogens directly from plasma, and neglected anatomy gets purpose-built devices.
Agents Become the Interface Layer
Microsoft’s Project Solara, Meta’s global WhatsApp Business Agent, and Morgan Stanley’s plan to open stock-administration platforms to external autonomous agents all point at the same interface shift. Microsoft framed Solara as an agent-first platform for new forms of computing, where agents become both a unit of programming and a unit of human-machine interaction. Meta is making its Business Agent available globally inside WhatsApp and Instagram DMs, with businesses paying through subscription tiers and larger customers charged by token usage. Morgan Stanley will let clients’ agents pull data directly from ShareWorks and Equity Edge, bypassing interfaces built for human users.
Each case lands in a different layer, collectively providing a pretty comprehensive overall picture. Microsoft is working at the device and operating-system layer, describing computers organized around agents, tasks, environments, and hardware built around the new workflow. Meta is working at the small-business communication layer, where customer support, recommendations, appointment booking, sales qualification, and overnight chat summaries become agent-mediated functions inside an app already used by businesses around the world. Morgan Stanley is working inside regulated financial infrastructure, where stock-plan administration connects to a wealth-management funnel that executives said has gathered $1.2 trillion in assets through the workplace strategy.
The Morgan Stanley example is especially revealing because it changes who the bank designs for. Mark Mitchell, chief product officer of Morgan Stanley at Work, told CNBC that in a future state corporate clients will no longer log into ShareWorks or Equity Edge. They will work through agentic systems on their own desktops, interacting with the bank's platforms through the Model Context Protocol. The bank has already granted early access to a handful of clients and plans to open the pathway to 3,400 administration clients by next year, extending the pattern the May 28 edition of The Century Report traced when Robinhood opened its trading platform and a virtual credit line to AI agents and explicitly disclaimed responsibility for the trades those agents might generate.
This is the app model bending. For decades, companies fought to make users enter through proprietary front doors: dashboards, portals, account pages, workflows, and notification systems. These announcements describe a world where the front door is less important because the user may never enter it directly. The durable value moves toward proprietary data, business logic, permissions, audit trails, and the ability to answer agent requests safely. If the old interface was a screen asking a person to click, the new one is a relationship among person, agent, institution, and record. That relationship is becoming software.
The old app model rested on a simple assumption: whoever owned the front door owned the relationship. Morgan Stanley’s MCP plan and Meta’s WhatsApp agents erode that assumption by making institutions answer permissioned requests from a person’s agent, with the portal demoted to one interface among many. The durable layer becomes data custody, revocation, logs, and trust.
The Other Side
For most of the era now ending, "creative work" came with a wage attached and a role to defend. Storyboard artists, concept designers, illustrators - each title named a slot in a production pipeline you trained to enter, joined to do, and protected to keep. The arrangement worked when getting an image from one head to another head required the work of a third head with specific skills. That arrangement is what the current dispute is actually about: not whether AI is good for creative work, but whether the slot structure can hold once the underlying skill becomes available to anyone with a vision.
Scorsese is the useful test case precisely because his own framing makes the issue legible. He is not commissioning generated images as final art. He is using a tool to put what he sees in his head into a form he can share. That is the work he says he has been doing himself by hand for fifty years - making storyboards as a private bridge to public production. The artists objecting are correct that their visual labor trained the systems involved. They are also describing a defense of the slot structure: the assumption that a director who needs visualization needs a specific other person whose job is to provide it. The deeper move in the dispute is that one of the most respected defenders of cinema is, in practice, demonstrating that the slot is dissolving.
Imagine a middle school student in 2036 interesting in making a short film. She has never held a camera and does not know how to draw. She has an idea - three minutes long, with a specific sense of pace and light and ache - and she spends the first afternoon describing it. By evening the system has rendered the look she described, sequence by sequence, and she is sitting with what she made, thinking about whether the third beat needs to be longer. None of the people whose images trained the system she used are anxious anymore about where the next month's rent comes from. They are, like her, making the things they want to make - some writing, some sculpting, some filming things their parents would have called hobbies because the market for those things in 2026 was thin. The casual ease of 2036 is that the question "who is allowed to make this" - asked in the name of the same extractive economic systems that made such questions necessary - stopped having to be answered before someone could just start creating.
The Century Perspective
With a century of change unfolding in a decade, a single day looks like this: brain disease moving from cellular atlas to genetic intervention, grid capacity assembling from homes and parked vehicles, tumor pharmacology becoming visible at single-cell resolution, clinical data becoming a discovery substrate, cinema’s most serious defenders testing generative imagery, and agents entering the operating system, the storefront, and the bank interface. There's also friction, and it's intense - biosecurity control points are being written after capability spreads, open models can automate cyber harm below the gated frontier, artists are demanding consent and credit, financial platforms are opening to agents before accountability norms have settled, and data-center demand keeps forcing the grid to redesign itself under pressure. But friction generates sparks, and sparks show where new circuits are ready to close. Step back for a moment and you can see it: capability widening through medicine, energy, creativity, and interfaces; access moving from specialized institutions toward working systems; scarcity assumptions meeting practical alternatives that are already cheaper, faster, or more measurable. Every transformation has a breaking point. A pulse can falter... or coordinate living systems into rhythm.
AI Releases & Advancements
New today
- Google: Released Gemma 4 12B, a new addition to the Gemma 4 open-weight family filling the gap between the existing mobile (E4B) and mid-range (26B MoE) tiers; the multimodal model runs on consumer laptops with 16GB RAM and matches 26B MoE on most benchmarks. (Google Blog)
- Ideogram: Released Ideogram 4.0, a 9.3B-parameter open-weight text-to-image model with native 2K resolution, transparent background generation, and bounding-box layout control; inference code is Apache 2.0, weights available under a non-commercial license; currently top-ranked open-weight model on DesignArena. (GitHub)
- Microsoft: Unveiled Majorana 2, a topological quantum chip with qubits 1,000× more reliable than its predecessor (mean lifetime 20 seconds vs. microseconds), and moved its timeline for a commercially valuable scalable quantum computer to 2029; also released Microsoft Discovery as generally available, a Frontier R&D platform deploying multi-agent science workflows, with a free downloadable Discovery app usable with a GitHub Copilot account. (Microsoft News)
- Anthropic: Launched Claude Security, a product using Claude Opus 4.8 to scan codebases for vulnerabilities and suggest patches, available to security teams; simultaneously expanded Project Glasswing to approximately 150 new organizations across 15+ countries covering power, water, healthcare, communications, and hardware sectors. (Anthropic)
- Microsoft: Released Aion 1.0 Instruct, an on-device small language model for Windows now available as a developer preview in Edge Canary and Dev channels, replacing the existing Windows OS SLM with a leaner model; a companion 14B reasoning model (Aion 1.0 Plan) for agentic on-device workflows is shipping to Windows devices in coming months. (Windows Developer Blog)
- Meta: Launched Meta Business Agent globally in WhatsApp and Instagram DMs, enabling businesses to deploy AI agents for customer support, product recommendations, appointment booking, and lead qualification; charges based on token usage for large businesses. (TechCrunch)
- Perplexity: Launched Personal Computer for Windows, expanding its locally-run AI agent (previously Mac-only) to Windows with integrations for Excel, PowerPoint, Word, Outlook, and OneDrive, and local file access across approved folders. (Perplexity)
- H Company: Released Holo3.1, a family of open-weight VLMs for computer-use agents (0.8B, 4B, 9B, and 35B-A3B) built on Qwen 3.5 finetunes; adds mobile environment support and native function-calling alongside the existing browser and desktop capabilities, with quantized checkpoints (FP8, Q4 GGUF, NVFP4) for fully local deployment; scores 25%+ improvement over Holo3 on the HoloTab harness. (H Company)
Other recent releases
- Microsoft: At Build 2026, released a family of seven new MAI models: MAI-Thinking-1 (first in-house reasoning model, 35B active parameters, 256K context, 53% on SWE-Bench Pro, available in private preview on Microsoft Foundry), MAI-Code-1-Flash (inference-efficient coding model now live in GitHub Copilot and VS Code), MAI-Image-2.5 and flash variant (text-to-image and image editing, ranked #2 on Arena AI leaderboard), MAI-Transcribe-1.5 (43-language streaming transcription), and MAI-Voice-2 (15 new languages). (Microsoft AI)
- Microsoft: Launched Scout in early access at Build 2026, an always-on personal AI assistant built on OpenClaw and WorkIQ that integrates with Teams, Outlook, and OneDrive to proactively handle scheduling, meeting prep, and email drafting without manual prompting; available to businesses starting this month. (Microsoft Blog)
- JetBrains: Open-sourced Mellum 2, a 12B MoE coding model with 2.5B active parameters (64 experts, 8 active per token); ships six variants (Base, Instruct, Thinking, and SFT editions) under Apache 2.0 on Hugging Face, with a Thinking variant that produces explicit reasoning traces for multi-step agentic tasks. (JetBrains AI Blog)
Sources and Further Reading
Artificial Intelligence & Technology's Reconstitution
- Ars Technica: GitHub Copilot Users React to Usage-Based Pricing
- Ars Technica: Android Phones Add Spoofed-Call and Impersonation Detection
- Ars Technica: Google’s Gemma 4 12B Runs on Laptops With 16GB of RAM
- Ars Technica: Microsoft’s Project Solara Is an Android OS Designed for Agents
- Microsoft: Project Solara at Build 2026
- The Verge: Microsoft Scout Assistant Enters Preview
- TechCrunch: Meta’s AI Agent for WhatsApp Business Is Available Globally
- Wired: OpenAI and Anthropic Sign Letter to Prevent AI-Developed Biological Weapons
- Gizmodo: AI Lab Leaders Sign Letter Against AI-Assisted Bioweapons
- The Register: Free Open-Source Model Powers Self-Spreading Worm in Enterprise Test Network
- Anthropic: Expanding Project Glasswing
- TechCrunch: Coralogix Raises $200M for AI-Agent Monitoring
- 404 Media: Google Is Buying Play Store Code to Train AI
- TechCrunch: Lovable Signs Multiyear Google Cloud Deal
- TechCrunch: Amazon Will Show AI Product Images in Search
Institutions & Power Realignment
- The Guardian: Martin Scorsese Accused of “Throwing Artists Under Bus” With AI Storyboards
- The Guardian: UK Media Websites Given Power to Block Google AI Search Use
- Ars Technica: Google Ordered to Let UK Publishers Opt Out of AI Search
- TechCrunch: Publishers Will Be Able to Opt Out of AI Search
- The Guardian: Colorado Governor Vetoes Surveillance-Pricing Ban
- The Guardian: California City Votes to Permanently Ban Datacenters
- The Guardian: Labour MP Sues xAI Over Fake Sexualized Images
- Ars Technica: Florida Sues OpenAI Over ChatGPT-Linked Murders
- The Guardian: Smartglasses and Earpieces May Worsen Exam Cheating
- Wired: Alpha School’s New York Campus Costs $65,000 but Is Not a School
Scientific & Medical Acceleration
- NPR: Allen Institute Launches Brain Health Accelerator
- Johns Hopkins University: Habits Form Faster Than Previously Thought
- BioSpace: Alnylam and Inceptive Form $2B RNAi Therapeutics Collaboration
- MobiHealthNews: Microsoft Partners With Mayo Clinic on Frontier Healthcare AI Model
- Nature Biotechnology: Spatial Pharmacobiology Maps Stromal Barriers to Antibody Delivery
- MedTech Dive: Edwards Gets FDA Approval for First Surgical Tricuspid Valve
- BioSpace: Zepto Life Receives FDA Breakthrough Device Designation for Mold-Infection Liquid Biopsy
- Nature Communications: EEG Response to Familiar Names Predicts Comatose ICU Outcomes
- Nature Biotechnology: Programmable Control of Bacterial Operons With Cas13
- MIT News: New Vaccine Adjuvant Could Help Eradicate Polio
- Nature Communications: Durable Electrodes for Industrial-Scale Seawater Splitting
- MIT News: Chemists Design Impact-Resistant Plastics
- Nature Communications: Spatial Chromatin Accessibility From Transcriptomics and Multi-Omics
- Angewandte Chemie: CRISPR Nanoplatform for Mutational mRNA Imaging
- Nature Physics: Evidence for Two Local Structures in Liquid Water
- Nature Communications: Ice-Phase Optothermal Tweezers
- Nature Catalysis: β-Lactam Annulation via Ni-Al Bimetallic Catalysis
- Nature Materials: Polyelectrolyte Elastomers With Higher Ionic Conductivity
- Nature: Limited Evidence of AI Superiority in Flu Vaccine Strain Selection
- Nature Medicine: Reinventing Biotech Systems for Patient Impact
Economics & Labor Transformation
- CNBC: Morgan Stanley Opens Wealth Management Funnel to AI Agents
- Bloomberg: Uber Caps AI System Usage to Cut Costs
- TechCrunch: Alphabet’s Record-Breaking $85B Raise for Google’s AI Business
- The Guardian: SpaceX Targets Biggest Ever Stock Market Debut
- The Guardian: OpenAI’s Mega-IPO Timing Question
- Wired: Quantum Computing’s Public Market Moment
- Bloomberg: CoreWeave-Tied Data Center Raises $900M in Junk Bonds
- Bloomberg: Broadcom Backing Lowers Debt Costs on $36B Anthropic Deal
- Forbes: Thrive Holdings Bets $1B on AI-Powered Accounting Roll-Up
- CNBC: Sellers Pull Homes Off Market at Fastest Pace Since 2020
Infrastructure & Engineering Transitions
- Utility Dive: Google to Fund 100-MW Virtual Power Plant in PJM
- Canary Media: Parked EVs Will Feed the Grid in Massachusetts
- Utility Dive: Three Mile Island Nuclear Restart Gets FERC Waiver
- Electrek: Another Giant Solar Factory Is Coming to Texas
- Canary Media: House Passes Measures to Speed Geothermal Projects
- Utility Dive: Seven States Sue Over TotalEnergies Offshore Wind Lease Buyout
- Microsoft: Majorana 2 Quantum Chip and Agentic AI Discovery
- Wired: Nvidia’s RTX Spark Laptops
- Wired: Unitree Humanoid Robot With Nvidia AI
The Century Report tracks structural shifts during the transition between eras. It is produced daily as a perceptual alignment tool - not prediction, not persuasion, just pattern recognition for people paying attention.